CHERYL YOUNG: Open Payments
NPI 1639158652 · ROCKLEDGE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$355 in 16 payments from 9 companies in 2025. Trend: 2023 $549 · 2024 $480 · 2025 $355
Food & beverage: $355
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 5 | $80 |
| GENZYME CORPORATION | 2 | $63 |
| Botanix SB Inc | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $39 |
| Lilly USA, LLC | 1 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Galderma Laboratories, L.P. | 1 | $20 |
| Amgen Inc. | 1 | $18 |
Products named: DUPIXENT, SOFDRA, BLU-U, TALTZ, NEMLUVIO, OTEZLA, VTAMA.
Industry payments across FL — which companies pay providers there.
